ED
CME icon

Exane Derivatives’s CME Group CME Stock Holding History

Exane Derivatives’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$205 Buy
+1
New +$212 ﹤0.01% 673
2022
Q1 		– Sell
-38
Closed -$8.92K – 1028
2021
Q4 		$8.68K Sell
38
-305
-89% -$67.1K ﹤0.01% 599
2021
Q3 		$66.3K Sell
343
-350
-51% -$70.9K 0.02% 592
2021
Q2 		$146K Buy
693
+9
+1% +$1.9K 0.03% 488
2021
Q1 		$140K Buy
684
+326
+91% +$64.2K 0.04% 347
2020
Q4 		$65.2K Sell
358
-65
-15% -$11.1K 0.02% 438
2020
Q3 		$70.8K Sell
423
-212
-33% -$35.7K 0.02% 349
2020
Q2 		$103K Sell
635
-132
-17% -$23.7K 0.03% 286
2020
Q1 		$133K Sell
767
-869
-53% -$173K 0.04% 246
2019
Q4 		$335K Sell
1,636
-925
-36% -$190K 0.06% 202
2019
Q3 		$541K Sell
2,561
-350
-12% -$73.1K 0.1% 161
2019
Q2 		$565K Sell
2,911
-2,280
-44% -$420K 0.1% 164
2019
Q1 		$854K Sell
5,191
-319
-6% -$56.4K 0.17% 127
2018
Q4 		$1.04M Hold
5,510
– – 0.19% 116
2018
Q3 		$947K Sell
5,510
-401
-7% -$67.5K 0.18% 113
2018
Q2 		$975K Buy
5,911
+486
+9% +$79.4K 0.16% 130
2018
Q1 		$863K Buy
5,425
+817
+18% +$130K 0.17% 129
2017
Q4 		$673K Sell
4,608
-627
-12% -$89.3K 0.12% 140
2017
Q3 		$710K Sell
5,235
-419
-7% -$52.9K 0.13% 107
2017
Q2 		$708K Sell
5,654
-726
-11% -$86.8K 0.15% 106
2017
Q1 		$758K Buy
6,380
+1,322
+26% +$159K 0.17% 103
2016
Q4 		$583K Sell
5,058
-1,257
-20% -$140K 0.12% 141
2016
Q3 		$660K Buy
6,315
+210
+3% +$21.9K 0.1% 140
2016
Q2 		$595K Sell
6,105
-100
-2% -$9.45K 0.1% 119
2016
Q1 		$596K Buy
6,205
+605
+11% +$55K 0.08% 125
2015
Q4 		$507K Buy
5,600
+129
+2% +$12.1K 0.07% 114
2015
Q3 		$507K Sell
5,471
-565
-9% -$53.7K 0.06% 125
2015
Q2 		$562K Buy
6,036
+1,175
+24% +$110K 0.06% 135
2015
Q1 		$461K Sell
4,861
-1,438
-23% -$133K 0.05% 149
2014
Q4 		$558K Buy
+6,299
New +$534K 0.08% 135

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Exane Derivatives's CME Position: Q2 2022 in Review

Exane Derivatives opened a new position in CME Group (CME) in Q2 2022: 1 share worth $205. The stake represents ﹤0.01% of the portfolio and ranks #673 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in CME as recently as Q4 2021.

Exane Derivatives first reported a position in CME in Q4 2014 and has held it in 30 quarters since. The position peaked at $1.04M in Q4 2018. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

  • Exane Derivatives held 1 share of CME Group worth $205 as of Q2 2022.
  • CME Group was a new Exane Derivatives position in Q2 2022.
  • CME Group made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #673 holding.
  • Exane Derivatives first reported a position in CME Group in Q4 2014 and has held it in 30 quarters since.
  • Exane Derivatives's CME Group position peaked at $1.04M in Q4 2018.
  • 1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.